EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RPTX: Repare Therapeutics Inc

30 Oct 25 08:00
LAST:

1.762

CHANGE:
 0.02		OPEN:
1.770		HIGH:
1.770		ASK:
0.000		VOLUME:
699
CHG(%):
0.99		PREV:
1.780		LOW:
1.760		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Oct 251.7701.7701.7601.762699
29 Oct 251.8001.8001.7501.780151.1K
28 Oct 251.8801.8851.7601.790287.0K
27 Oct 251.8601.9101.8101.870197.0K
24 Oct 251.9301.9701.9101.960208.2K
23 Oct 251.8801.9701.8801.930205.0K
22 Oct 251.8801.9401.8701.910242.1K
21 Oct 251.8701.8901.8401.880116.2K
20 Oct 251.8501.8801.8301.880142.3K
17 Oct 251.8301.8601.7301.830545.7K

COMPANY PROFILE

Name:Repare Therapeutics Inc
About:Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Sector:Healthcare
Industry:Biotechnology
Address:7171 Frederick-Banting, Building 2, Montreal, QC, Canada, H4S 1Z9
Website:https://www.reparerx.com
CUSIP:760273102
CIK:0001808158
ISIN:US7602731025
FIGI:BBG00V5N3WP4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.834.0%
MA10:1.865.5%
MA20:1.854.8%
MA50:1.760.1%
MA100:1.638.2%
MA200:1.4323.4%
RSI14:46.22
WPR14:-100.00 
MTM14:-0.06
ROC14:-0.03 
ATR:0.09 
Week High:1.9711.8%
Week Low:1.750.7%
Month High:1.9711.8%
Month Low:1.6823.4%
Year High:4.07130.9%
Year Low:0.8998.0%
Volatility:13.01